STOCK TITAN

Silicon Labs Reports First Quarter 2026 Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Silicon Labs (NASDAQ: SLAB) reported Q1 2026 results for the quarter ended April 4, 2026: revenue $214 million (up 20% YoY) and non-GAAP diluted EPS $0.53. GAAP results showed a $17 million operating loss and GAAP diluted loss per share of $0.48. The company suspended guidance because of the pending Texas Instruments acquisition.

Industrial & Commercial revenue was $128 million (up 33% YoY); Home & Life revenue was $86 million (up 5% YoY). Non-GAAP operating income was $18 million and non-GAAP gross margin was 59.7%.

Loading...
Loading translation...

Positive

  • Revenue $214M, +20% year-over-year
  • Non-GAAP EPS $0.53 for Q1 2026
  • Industrial & Commercial revenue $128M, +33% year-over-year
  • Non-GAAP operating income $18M and gross margin 59.7%
  • Book-to-bill at multi-year high and record design wins

Negative

  • GAAP operating loss $17M for Q1 2026
  • GAAP diluted loss per share $(0.48)
  • GAAP operating expenses $144M (higher than non-GAAP basis)
  • Guidance suspended due to pending acquisition by Texas Instruments

Key Figures

Q1 2026 revenue: $214 million Industrial & Commercial revenue: $128 million Home & Life revenue: $86 million +5 more
8 metrics
Q1 2026 revenue $214 million First quarter 2026, up 20% year-over-year
Industrial & Commercial revenue $128 million Q1 2026, up 33% year-over-year
Home & Life revenue $86 million Q1 2026, up 5% year-over-year
GAAP gross margin 59.5% Q1 2026 reported basis
GAAP operating loss $17 million Q1 2026
GAAP diluted loss per share $(0.48) Q1 2026
Non-GAAP operating income $18 million Q1 2026, excludes specified items
Non-GAAP EPS $0.53 Q1 2026 diluted earnings per share

Market Reality Check

Price: $217.00 Vol: Volume 301,829 is at 0.73...
normal vol
$217.00 Last Close
Volume Volume 301,829 is at 0.73x the 20-day average (413,362). normal
Technical Price 217.00 is trading above the 200-day MA at 157.46 and near the 52-week high of 218.46.

Peers on Argus

SLAB is down 0.57% while close peers show mixed moves: SMTC -1.02%, PI -3.07%, S...
1 Up

SLAB is down 0.57% while close peers show mixed moves: SMTC -1.02%, PI -3.07%, SYNA +4.35%, ALGM +0.10%, CRUS +0.05%. Only QRVO appears in momentum scans, up 1.09% without news.

Previous Earnings Reports

5 past events · Latest: Feb 04 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 04 Earnings results Positive +48.9% Full-year 2025 results with strong revenue growth and non-GAAP profitability.
Jan 22 Earnings webcast Neutral -0.3% Announcement of schedule and access details for Q4 2025 earnings call.
Nov 04 Earnings results Positive -0.9% Q3 2025 results with revenue growth and both GAAP loss and non-GAAP profit.
Oct 07 Earnings webcast Neutral -2.5% Announcement of timing and webcast details for Q3 2025 earnings release.
Aug 05 Earnings results Positive -5.1% Q2 2025 results with strong revenue growth and segment strength in IoT.
Pattern Detected

Earnings and related communications have produced mixed reactions: one prior earnings release saw a large gain, while several other earnings and webcast announcements drew modest negative moves, indicating inconsistent trading responses to financial updates.

Recent Company History

Recent history for Silicon Labs shows multiple earnings-related catalysts. A prior earnings release on Feb 4, 2026 with strong full‑year 2025 results saw a 48.89% move. Earlier, Q3 2025 results on Nov 4, 2025 and Q2 2025 results on Aug 5, 2025 highlighted solid revenue growth and non‑GAAP profitability, yet shares moved modestly lower after both reports. Earnings webcast announcements in Jan 2026 and Oct 2025 generated small, mixed price reactions. Against this backdrop, the latest Q1 2026 earnings continue the pattern of strong operational metrics with uneven share-price responses.

Historical Comparison

+8.0% avg move · Past 12 months include 5 earnings-related events averaging a ±8% move. Today’s modest -0.57% reactio...
earnings
+8.0%
Average Historical Move earnings

Past 12 months include 5 earnings-related events averaging a ±8% move. Today’s modest -0.57% reaction to Q1 2026 results sits well within that historical range.

Earnings updates show a progression of growing IoT revenue and recurring non-GAAP profitability from Q2 and Q3 2025 into full-year 2025 and now Q1 2026, alongside ongoing merger-related communications.

Market Pulse Summary

This announcement highlights Q1 2026 revenue of $214 million, 20% year-over-year growth, and non-GAA...
Analysis

This announcement highlights Q1 2026 revenue of $214 million, 20% year-over-year growth, and non-GAAP EPS of $0.53 alongside continued GAAP losses. Industrial & Commercial and Home & Life segments both expanded, with notable strength in electronic shelf labels and smart metering. Historically, earnings updates have produced mixed share reactions, so attention may center on sustained non-GAAP profitability, segment momentum, and the ongoing merger process with Texas Instruments as key factors to monitor.

Key Terms

non-gaap, gaap, book-to-bill ratio
3 terms
non-gaap financial
"Results on a non-GAAP basis, excluding the impact of stock compensation..."
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
gaap financial
"Results on a GAAP basis:GAAP gross margin was 59.5%GAAP operating expenses..."
GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.
book-to-bill ratio financial
"Our leading indicators point to both near- and long-term strength, with book-to-bill ratio at a multi-year high..."
The book-to-bill ratio compares the value of new orders a company receives to the value of products it ships out or bills for over a certain period. If the ratio is above 1, it means the company is getting more orders than it is completing, which can indicate growth. If it's below 1, it suggests demand is slowing down.

AI-generated analysis. Not financial advice.

Wireless IoT leader delivers $214 million in revenue and non-GAAP EPS of $0.53

AUSTIN, Texas, May 5, 2026 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the first quarter, which ended April 4, 2026.

"The Silicon Labs team delivered a strong start to 2026 with revenue of $214 million and meaningful year-over-year improvements in both gross margin and profitability," said Matt Johnson, President and Chief Executive Officer.

"Over the course of the quarter we saw an acceleration in bookings with declining inventory positions at our distributors and end customers, led by our broad industrial business. Design win momentum continued during the first quarter, exceeding both our internal targets and our 2025 run rate, which was a prior record year for the company. This performance underscores the breadth and depth of our innovative product portfolio across end applications.

Our leading indicators point to both near- and long-term strength, with book-to-bill ratio at a multi-year high and two quarters of record design wins, reinforcing our conviction in Silicon Labs' durable growth trajectory. At the same time, our proposed merger with Texas Instruments continues to advance, and we remain focused on disciplined execution and delivering for our customers."

First Quarter Financial Highlights

  • Revenue was $214 million, up 20% year-over-year
  • Industrial & Commercial revenue was $128 million, up 33% year-over-year
    • Strength in electronic shelf labels and smart metering end applications
  • Home & Life revenue was $86 million, up 5% year-over-year
    • Medical end applications revenue grew by 21% year-over-year

Results on a GAAP basis:

  • GAAP gross margin was 59.5%
  • GAAP operating expenses were $144 million
  • GAAP operating loss was $17 million
  • GAAP effective tax rate was (16.1)%
  • GAAP diluted loss per share was $(0.48)

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, acquisition-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

  • Non-GAAP gross margin was 59.7%
  • Non-GAAP operating expenses were $109 million
  • Non-GAAP operating income was $18 million
  • Non-GAAP effective tax rate was 18%, which is the expected long-term rate for the remainder of the year
  • Non-GAAP diluted earnings per share was $0.53

Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding Silicon Labs' current expectations, which are based on its current views and assumptions. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward-looking. These forward-looking statements include, but are not limited to, Silicon Labs' expectations regarding its near- and long-term strength and durable growth trajectory and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)



Three Months Ended


April 4,
2026


April 5,
2025

Revenues

$       213,500


$       177,714

Cost of revenues

86,502


79,937

Gross profit

126,998


97,777

Operating expenses:




Research and development

88,594


88,219

Selling, general and administrative

55,486


41,638

Operating expenses

144,080


129,857

Operating loss

(17,082)


(32,080)

Other income (expense):




Interest income and other, net

3,626


3,793

Interest expense

(232)


(284)

Loss before income taxes

(13,688)


(28,571)

Provision for income taxes

2,209


1,899

Net loss

$        (15,897)


$        (30,470)





Loss per share:




Basic

$          (0.48)


$          (0.94)

Diluted

$          (0.48)


$          (0.94)





Weighted-average common shares outstanding:




Basic

32,963


32,465

Diluted

32,963


32,465

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)




Three Months Ended

April 4, 2026

Non-GAAP Income
Statement Items


GAAP

Measure


GAAP

Percent of

Revenue


Stock

Compensation

Expense


Intangible
Asset

Amortization


Acquisition-
Related Costs


Other Costs


Non-GAAP

Measure


Non-GAAP

Percent of

Revenue

Revenues


$ 213,500
































Gross profit


126,998


59.5 %


$         442


$          —


$          —


$   —


$ 127,440


59.7 %


















Research and development


88,594


41.5 %


11,416


2,295



664


74,219


34.8 %


















Selling, general and
administrative


55,486


26.0 %


9,197



11,213



35,076


16.4 %


















Operating expenses


144,080


67.5 %


20,613


2,295


11,213


664


109,295


51.2 %


















Operating income (loss)


(17,082)


(8.0 %)


21,055


2,295


11,213


664


18,145


8.5 %

 






Three Months Ended

April 4, 2026

Non-GAAP Earnings (Loss)
Per Share


GAAP

Measure


Stock

Compensation

Expense*


Intangible

Asset

Amortization*


Acquisition-
Related
Costs*


Other

Costs*


Income

Tax

Adjustments**


Non-

GAAP

Measure

Net income (loss)


$  (15,897)


$     21,055


$       2,295


$      11,213


$     664


$       (1,668)


$     17,662




















Shares Excluded Due to Net Loss



Diluted shares outstanding


32,963


585


33,548
















Diluted earnings (loss) per share


$    (0.48)












$        0.53

*  Represents pre-tax amounts


**  Represents the application of an 18% non-GAAP tax rate

 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)



April 4,
2026


January 3,
2026

Assets




Current assets:




Cash and cash equivalents

$       383,089


$       364,222

Short-term investments

55,767


79,400

Accounts receivable, net

77,120


64,513

Inventories

103,232


95,566

Prepaid expenses and other current assets

57,113


70,316

Total current assets

676,321


674,017

Property and equipment, net

131,821


128,643

Goodwill

376,389


376,389

Other intangible assets, net

20,836


23,130

Other assets, net

61,094


67,138

Total assets

$     1,266,461


$     1,269,317

Liabilities and Stockholders' Equity




Current liabilities:




Accounts payable

$         56,384


$         50,717

Deferred revenue and returns liability

9,822


5,359

Other current liabilities

66,273


87,711

Total current liabilities

132,479


143,787

Other non-current liabilities

35,448


31,112

Total liabilities

167,927


174,899

Commitments and contingencies




Stockholders' equity:




Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued


Common stock – $0.0001 par value; 250,000 shares authorized; 32,968 and 32,955
shares issued and outstanding at April 4, 2026 and January 3, 2026, respectively

3


3

Additional paid-in capital

177,551


157,402

Retained earnings

920,917


936,814

Accumulated other comprehensive income

63


199

Total stockholders' equity

1,098,534


1,094,418

Total liabilities and stockholders' equity

$     1,266,461


$     1,269,317

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)



Three Months Ended


April 4,
2026


April 5,
2025

Operating Activities




Net loss

$        (15,897)


$        (30,470)

Adjustments to reconcile net loss to net cash provided by operating activities:




Depreciation of property and equipment

6,047


6,248

Amortization of other intangible assets

2,295


5,437

Stock-based compensation expense

21,055


19,714

Deferred income taxes

1,153


(1,514)

Changes in operating assets and liabilities:




Accounts receivable

(12,608)


2,412

Inventories

(7,616)


22,098

Prepaid expenses and other assets

6,813


2,973

Accounts payable

3,387


9,234

Other current liabilities and income taxes

(7,415)


11,870

Deferred revenue and returns liability

4,463


3,405

Other non-current liabilities

3,257


(3,279)

Net cash provided by operating activities

4,934


48,128





Investing Activities




Purchases of marketable securities


(19,728)

Sales of marketable securities


10,005

Maturities of marketable securities

23,461


10,675

Purchases of property and equipment

(9,837)


(4,852)

Proceeds from capital-related government incentives

1,265


Net cash provided by (used in) investing activities

14,889


(3,900)





Financing Activities




Payment of taxes withheld for vested stock awards

(956)


(958)

Net cash used in financing activities

(956)


(958)





Increase in cash and cash equivalents

18,867


43,270

Cash and cash equivalents at beginning of period

364,222


281,607

Cash and cash equivalents at end of period

$       383,089


$       324,877

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-first-quarter-2026-results-302763148.html

SOURCE Silicon Labs

FAQ

What were Silicon Labs (SLAB) Q1 2026 revenue and EPS results?

Q1 2026 revenue was $214 million and non-GAAP diluted EPS was $0.53. According to the company, GAAP results included a $17 million operating loss and GAAP diluted loss per share of $0.48.

How did Silicon Labs (SLAB) perform by segment in Q1 2026?

Industrial & Commercial revenue was $128 million, up 33% year-over-year; Home & Life was $86 million, up 5%. According to the company, strength came from electronic shelf labels, smart metering, and medical applications.

What margins and operating income did SLAB report for Q1 2026?

Non-GAAP gross margin was 59.7% and non-GAAP operating income was $18 million. According to the company, GAAP gross margin was 59.5% with higher GAAP operating expenses driving a reported GAAP loss.

Why did Silicon Labs (SLAB) suspend forward-looking guidance after Q1 2026?

Guidance was suspended because of the pending acquisition by Texas Instruments. According to the company, the transaction timing and integration process create uncertainty for providing forward-looking guidance.

What operational indicators did SLAB cite that suggest demand momentum?

The company reported a multi-year high book-to-bill ratio and two quarters of record design wins. According to the company, bookings accelerated while distributor and end-customer inventories declined during the quarter.